Arvinas Inc
(NAS:ARVN)
$
25.98
1.5 (6.13%)
Market Cap: 1.79 Bil
Enterprise Value: 665.07 Mil
PE Ratio: 0
PB Ratio: 3.05
GF Score: 72/100 Arvinas Inc at Stifel Targeted Oncology Days (Virtual) Transcript
Apr 26, 2023 / 03:30PM GMT
Release Date Price:
$27.13
(+0.41%)
Brad Canino
Stifel Financial Corp. - Analyst
All right. Thanks, everyone, for continuing to join us on the inaugural Stifel Targeted Oncology Days. My name is Brad Canino, senior analyst here at Stifel; delighted to host for a fireside chat Arvinas. We've got Ian Taylor, Chief Scientific Officer; and Sean Cassidy, Chief Financial Officer. So thank you both for [agreeing to stand and have a chat].
Sean Cassidy
Arvinas, Inc. - CFO & Treasurer
Yeah, thanks, Brad.
Ian Taylor
Arvinas, Inc. - Chief Scientific Officer
Thanks for having us.
Sean Cassidy
Arvinas, Inc. - CFO & Treasurer
Thanks for having us.
Questions & Answers
Brad Canino;Sean Cassidy
Stifel Financial Corp. - Analyst;
Yeah. And Sean, if I just could have you start out with a quick overview of the company, maybe status of the clinical oncology programs as well that we'll be discussing for the rest of the talk.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot